EU Appro For Kolmi/Molnlycke Clinical Merger

The European Commission has approved the merger of Kolmi, owned byFinnish firm Tamro, and Molnlycke Clinical, a unit of Swedish firm SCA Molnlycke. declaring the operation compatible with the common market.

Agreement was reached last November by Tamro and SCA Molnlycke to sell their divisions manufacturing surgical and wound management products to a new company which is to be established as Molnlycke HealthCare AB. The Swedish investors in this are represented by Nordic Capital, which will own 70% while Tamro will hold 30% of the new firm, which has estimated net sales of around 2 billion Swedish kroner ($248.4 million). The company has factories in Finland, Sweden, Belgium, Austria, France, Ireland and Thailand.